NO138661C - Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 1-(4-cyano-fenoxy)-2-hydroxy-3-(2-(5-1h-tetrazolyl)-chromonyloxy)-propan - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 1-(4-cyano-fenoxy)-2-hydroxy-3-(2-(5-1h-tetrazolyl)-chromonyloxy)-propanInfo
- Publication number
- NO138661C NO138661C NO4621/73A NO462173A NO138661C NO 138661 C NO138661 C NO 138661C NO 4621/73 A NO4621/73 A NO 4621/73A NO 462173 A NO462173 A NO 462173A NO 138661 C NO138661 C NO 138661C
- Authority
- NO
- Norway
- Prior art keywords
- chromonyloxy
- tetrazolyl
- phenoxy
- propane
- cyano
- Prior art date
Links
- -1 1- (4-CYANO-PHENOXY) -2-HYDROXY-3- (2- (5-1H-TETRAZOLYL) -CHROMONYLOXY) -PROPANE Chemical compound 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5611772A GB1457254A (en) | 1972-12-05 | 1972-12-05 | 1-phenoxy-2-hydroxy-3-chromonyloxy-propane derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO138661B NO138661B (no) | 1978-07-10 |
| NO138661C true NO138661C (no) | 1978-10-18 |
Family
ID=10475767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO4621/73A NO138661C (no) | 1972-12-05 | 1973-12-04 | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 1-(4-cyano-fenoxy)-2-hydroxy-3-(2-(5-1h-tetrazolyl)-chromonyloxy)-propan |
Country Status (16)
| Country | Link |
|---|---|
| JP (2) | JPS533392B2 (cs) |
| AR (1) | AR199426A1 (cs) |
| AU (1) | AU460893B2 (cs) |
| BE (1) | BE808190A (cs) |
| CA (1) | CA1016178A (cs) |
| CH (1) | CH585749A5 (cs) |
| DE (1) | DE2360355C3 (cs) |
| ES (1) | ES421133A1 (cs) |
| FR (1) | FR2208674B1 (cs) |
| GB (1) | GB1457254A (cs) |
| HU (1) | HU166457B (cs) |
| IL (1) | IL43761A (cs) |
| NL (1) | NL179056C (cs) |
| NO (1) | NO138661C (cs) |
| SE (3) | SE404605B (cs) |
| ZA (1) | ZA739197B (cs) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5811141U (ja) * | 1981-07-14 | 1983-01-24 | 本田技研工業株式会社 | ブレ−キデイスク |
| JPS5834235U (ja) * | 1981-08-28 | 1983-03-05 | カシオ計算機株式会社 | 押釦スイツチの可動接片 |
| US5659051A (en) * | 1993-07-13 | 1997-08-19 | Sumitomo Chemical Company, Limited | Process of producing 2-cyano-4-oxo-4H-benzopyran compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3965122A (en) * | 1970-12-30 | 1976-06-22 | Fujisawa Pharmaceutical Co., Ltd. | Chromone compounds and preparation thereof |
-
1972
- 1972-12-05 GB GB5611772A patent/GB1457254A/en not_active Expired
-
1973
- 1973-11-28 CA CA186,922A patent/CA1016178A/en not_active Expired
- 1973-12-03 AU AU63133/73A patent/AU460893B2/en not_active Expired
- 1973-12-04 SE SE7316374A patent/SE404605B/xx unknown
- 1973-12-04 AR AR251355A patent/AR199426A1/es active
- 1973-12-04 ES ES421133A patent/ES421133A1/es not_active Expired
- 1973-12-04 CH CH1697673A patent/CH585749A5/xx not_active IP Right Cessation
- 1973-12-04 HU HUMI549A patent/HU166457B/hu unknown
- 1973-12-04 ZA ZA739197A patent/ZA739197B/xx unknown
- 1973-12-04 NO NO4621/73A patent/NO138661C/no unknown
- 1973-12-04 NL NLAANVRAGE7316575,A patent/NL179056C/xx not_active IP Right Cessation
- 1973-12-04 JP JP13645773A patent/JPS533392B2/ja not_active Expired
- 1973-12-04 BE BE138487A patent/BE808190A/xx not_active IP Right Cessation
- 1973-12-04 DE DE2360355A patent/DE2360355C3/de not_active Expired
- 1973-12-04 FR FR7343175A patent/FR2208674B1/fr not_active Expired
- 1973-12-05 IL IL43761A patent/IL43761A/en unknown
-
1974
- 1974-04-01 JP JP3572274A patent/JPS5336016B2/ja not_active Expired
-
1977
- 1977-01-21 SE SE7700663A patent/SE408420B/xx unknown
- 1977-01-21 SE SE7700664A patent/SE408421B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES421133A1 (es) | 1976-04-16 |
| SE7700664L (sv) | 1977-01-21 |
| FR2208674B1 (cs) | 1977-01-28 |
| JPS533392B2 (cs) | 1978-02-06 |
| GB1457254A (en) | 1976-12-01 |
| NL179056C (nl) | 1986-07-01 |
| SE7700663L (sv) | 1977-01-21 |
| JPS5336016B2 (cs) | 1978-09-30 |
| JPS4993367A (cs) | 1974-09-05 |
| AR199426A1 (es) | 1974-08-30 |
| BE808190A (fr) | 1974-03-29 |
| ZA739197B (en) | 1974-10-30 |
| SE408421B (sv) | 1979-06-11 |
| CA1016178A (en) | 1977-08-23 |
| SE408420B (sv) | 1979-06-11 |
| CH585749A5 (cs) | 1977-03-15 |
| HU166457B (cs) | 1975-03-28 |
| DE2360355C3 (de) | 1979-06-07 |
| NO138661B (no) | 1978-07-10 |
| DE2360355B2 (de) | 1978-10-12 |
| AU460893B2 (en) | 1975-05-08 |
| NL179056B (nl) | 1986-02-03 |
| NL7316575A (cs) | 1974-06-07 |
| FR2208674A1 (cs) | 1974-06-28 |
| JPS50111219A (cs) | 1975-09-01 |
| IL43761A (en) | 1977-10-31 |
| SE404605B (sv) | 1978-10-16 |
| DE2360355A1 (de) | 1974-06-20 |
| AU6313373A (en) | 1975-05-08 |
| IL43761A0 (en) | 1974-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO140056C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive olefinisk 4-substituerte piperidino-derivater | |
| NO138565C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater | |
| NO144455C (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive nye piperidinderivater. | |
| NO141687C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-oxo-2,2-disubstituerte-5-indanyloxy-eddiksyrer | |
| NO138566C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater | |
| NO142865C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler | |
| NO140058C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater | |
| NO143846C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater | |
| NO140977C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner | |
| NO138564C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 1-(2-carboxy-chromon-5-yloxy)-2-(hydroxy)-3-(p-cyanfenoxy) propan eller derivater herav | |
| NO141648C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 2-oxazolinderivater | |
| NO140348C (no) | Analogifremgangsmaate til fremstilling av nye terapeutisk aktive 3-(amino-2-hydroksypropoksy)-isoindolin-1-on-forbindelser | |
| NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
| DK137239C (da) | Fremgangsmaade til fremstilling af terapeutisk aktive 2-(3'-hydroxyphenyl)-1-oxa-4-azaspiroalkan-derivater | |
| NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
| NO144108C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider | |
| NO138661C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 1-(4-cyano-fenoxy)-2-hydroxy-3-(2-(5-1h-tetrazolyl)-chromonyloxy)-propan | |
| NO138660C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 3-(piperazinalkyl)-2,4-kinazolindioner | |
| NO136092C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktiv 4-(4-bifenyl)-1-butanol. | |
| NO140186C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye 2-(2-pyridyl)-3-(p-klorfenyl)-propylaminer | |
| NO138025C (no) | Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler | |
| NO144110C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater | |
| NO138568C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 21-(bea-benzoylaminoisobutyryl)-16alfa,17alfa-(p-dimethyl-aminobenzyliden)-triamcinolon | |
| NO138598C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-delta2-imidazolinyl)-2,2-diarylcyklopropaner og deres syreaddisjonssalter | |
| NO140299C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner |